All articles by GlobalData 

  1. Jardiance fails to deliver in EMPERIAL trials for heart failure

    Boehringer Ingelheim and Eli Lilly’s collaborative effort to secure Jardiance’s (empagliflozin’s) place in the heart failure (HF) landscape has reached…
    Read More…

    23 Dec
  2. Astellas expands into gene therapy with $3bn acquisition of Audentes

    California-based Audentes is a clinical-stage company that focuses on developing adeno-associated virus (AAV)-based gene therapies for serious rare neuromuscular diseases….
    Read More…

    10 Dec
  3. Evaluating NICE guidelines in regards to cannabis-based medicinal products targeting pain

    For the first time, the UK’s National Institute for Health and Care Excellence (NICE) granted approval for two cannabis-based medicines,…
    Read More…

    5 Dec
  4. IDWeek 2019: Long-acting antiretroviral therapy shows promise for HIV patients with low adherence

    During IDWeek 2019 in Washington DC, Joe Eron from UNC Chapel Hill and Paula Teichner from ViiV Healthcare presented data…
    Read More…

    8 Oct
  5. Global Blood Therapeutics leads in world sickle cell disease trials

    To mark sickle cell awareness month in the US, GlobalData took a comprehensive look at the global sickle cell disease…
    Read More…

    25 Sep
  6. Trends in clinical trials for gene therapies in neurology

    Gene therapies have been garnering attention due to the high costs attached to recently approved therapies and the potential for…
    Read More…

    23 Sep
  7. Top ten drugs in biosimilar trials globally

    Over the past decade, the number of clinical trials using a biosimilar treatment has been on the rise. GlobalData extracted…
    Read More…

    1 May
  8. Governments are playing a bigger role in cell and gene therapy manufacturing

    Government institutions are becoming increasingly engaged in cell and gene therapy manufacturing across the US and UK industries, according to…
    Read More…

    10 Apr
Close
Close
Close

Go Top